Tredje AP-fonden’s iShares Biotechnology ETF IBB Stock Holding History

Tredje AP-fonden’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-70,000	Closed	-$9.12M	–	321
2022 Q1	$9.12M	Buy	+70,000	New	+$9.12M	0.19%	109
2015 Q4	–	Sell	-120,000	Closed	-$563K	–	301
2015 Q3	$563K	Buy	+120,000	New	+$14.4M	0.06%	273

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Tredje AP-fonden's IBB Position: Q2 2022 in Review

Tredje AP-fonden sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 70,000 shares — an estimated $9.12M sold.

Tredje AP-fonden first reported a position in IBB in Q3 2015 and held it in 2 quarters. The position peaked at $9.12M in Q1 2022. 859 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Tredje AP-fonden reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Tredje AP-fonden sold 70,000 iShares Biotechnology ETF shares in Q2 2022, an estimated $9.12M.
Tredje AP-fonden first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 2 quarters.
Tredje AP-fonden's iShares Biotechnology ETF position peaked at $9.12M in Q1 2022.
859 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Tredje AP-fonden's 13F filing for Q2 2022, filed 10 Aug 2022.